Showing results (11-20 of 73) with videos related to

Sort By:
Pageof 8
CPT: Pharmacometrics & Systems Pharmacology|August 19, 2024
Bayesian sparse regression for exposure-response analyses of efficacy and safety endpoints to justify the clinical dose of valemetostat for adult T-cell leukemia/lymphomaMasato Fukae, James Rogers, Ramon Garcia, et al.
Drug Metabolism and Pharmacokinetics|May 1, 2008
Additional notes on clinical repeated-dose pharmacokinetic trials applying a peak-and-trough sampling design to estimate oral clearanceMari Takaai, Yuichiro Kayano, Takako Shimizu, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 30, 2024
Population pharmacokinetics of total and unbound valemetostat and platelet dynamics in healthy volunteers and patients with non-Hodgkin lymphomaMasato Fukae, Kyle Baron, Masaya Tachibana, et al.
Biological & Pharmaceutical Bulletin|October 6, 2007
Stereoselective metabolism of carvedilol by the beta-naphthoflavone-inducible enzyme in human intestinal epithelial Caco-2 cellsKazuya Ishida, Mutsuko Honda, Takako Shimizu, et al.
Endocrinology|November 26, 2002
Role of ghrelin in streptozotocin-induced diabetic hyperphagiaShinya Ishii, Jun Kamegai, Hideki Tamura, et al.
British Journal of Clinical Pharmacology|April 25, 2018
Single- and multiple-dose escalation study to assess pharmacokinetics, pharmacodynamics and safety of oral esaxerenone in healthy Japanese subjectsManabu Kato, Hidetoshi Furuie, Takako Shimizu, et al.
Rinsho Shinkeigaku = Clinical Neurology|November 15, 2013
[]An adult case of mumps-associated encephalitis/encephalopathy successfully treated with steroid pulse therapy]Daisuke Yamamoto, Tsuyoshi Uchiyama, Takashi Sugiyama, et al.
Clinical and Translational Science|July 7, 2025
Effect of Rifampicin on the Pharmacokinetics of Valemetostat and Its Primary Metabolite: A Phase 1 Study in Healthy ParticipantsMasaya Tachibana, Shunji Matsuki, Akifumi Kurata, et al.
Neuroendocrinology|December 23, 2003
Hypothalamic neuropeptide Y/Y1 receptor pathway activated by a reduction in circulating leptin, but not by an increase in circulating ghrelin, contributes to hyperphagia associated with triiodothyronine-induced thyrotoxicosisShinya Ishii, Jun Kamegai, Hideki Tamura, et al.
Regulatory Peptides|April 20, 2004
Effects of insulin, leptin, and glucagon on ghrelin secretion from isolated perfused rat stomachJun Kamegai, Hideki Tamura, Takako Shimizu, et al.
Pageof 8